Ranolazine as an adjunct to standard therapy for angina in myocardial bridging: a randomized clinical trial

Abstract Myocardial bridging (MB) is a common anatomical variation in which myocardial fibers traverse over an epicardial coronary artery, potentially leading to angina or angina- equivalent symptoms. Ranolazine, known for its efficacy in chronic stable angina, might offer benefits in symptomatic MB...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Alireza Abdi-Ardekani, Nasim Kheirandish, Seyed Yaser Rahbarian, Mohammad Hossein Imani, Alireza Arzhangzadeh, Amirhossein Saem, Maliheh Kamali, Helia Bazroodi, Sana Neisi, Mitra Mojibpour, Amir Hossein Imani, Mehdi Bazrafshan, Hamed Bazrafshan Drissi
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2026-04-01
Serija:	Scientific Reports
Teme:	Myocardial bridging Coronary bridge Angina Ranolazine β-blockers Chest pain class
Online dostop:	https://doi.org/10.1038/s41598-026-45404-5
Oznake:	Označite Brez oznak, prvi označite!